Literature DB >> 22955103

Atheroprotective mechanisms of shear stress-regulated microRNAs.

Reinier A Boon1, Eduard Hergenreider, Stefanie Dimmeler.   

Abstract

MicroRNAs (miRs) are small non-coding RNAs that control gene expression by inhibiting translation or inducing degradation of targeted mRNA. miRs play a crucial role in vascular homeostasis but also during pathophysiological processes. Functionally active endothelial cells maintain homeostasis of the vasculature and protect against cardiovascular disease. The mechanical activation of endothelial cells by laminar shear stress provides a potent atheroprotective effect and reduces endothelial inflammation and cell cycle progression. Laminar shear stress induces profound changes in gene expression and recently was shown to regulate various miRs. The down-regulation of miR-92a by shear stress enhances the expression of the endothelial nitric oxide synthase, whereas the up-regulation of miR-19a contributes to the shear stress-induced inhibition of cell proliferation. In addition, members of the miR-23-27-24 cluster are increased and specifically miR-23b blocks cell cycle progression, whereas miR-27b was shown to reduce endothelial cell repulsive signals. Finally, increased miR-10 expression in atheroprotected regions reduced the inflammatory response of endothelial cells and increased endothelial miR-143/145 levels improved smooth muscle cells functions. Together, the regulation of miRs by shear stress contributes to the anti-inflammatory, cell cycle inhibitory and vasculoprotective effects in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955103     DOI: 10.1160/TH12-07-0491

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  21 in total

1.  Chronic hypertension increases aortic endothelial hydraulic conductivity by upregulating endothelial aquaporin-1 expression.

Authors:  Jimmy Toussaint; Chirag Bharavi Raval; Tieuvi Nguyen; Hadi Fadaifard; Shripad Joshi; George Wolberg; Steven Quarfordt; Kung-Ming Jan; David S Rumschitzki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-21       Impact factor: 4.733

2.  Dual inhibition of endothelial miR-92a-3p and miR-489-3p reduces renal injury-associated atherosclerosis.

Authors:  Carrie B Wiese; Jianyong Zhong; Zhi-Qi Xu; Youmin Zhang; Marisol A Ramirez Solano; Wanying Zhu; MacRae F Linton; Quanhu Sheng; Valentina Kon; Kasey C Vickers
Journal:  Atherosclerosis       Date:  2019-01-30       Impact factor: 5.162

Review 3.  Endothelial microRNAs and atherosclerosis.

Authors:  Xinghui Sun; Nathan Belkin; Mark W Feinberg
Journal:  Curr Atheroscler Rep       Date:  2013-12       Impact factor: 5.113

Review 4.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 5.  Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease.

Authors:  Naomi M Hamburg; Nicholas J Leeper
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

Review 6.  Role of miR-181 family in regulating vascular inflammation and immunity.

Authors:  Xinghui Sun; Alan Sit; Mark W Feinberg
Journal:  Trends Cardiovasc Med       Date:  2013-11-01       Impact factor: 6.677

7.  Reduction in MicroRNA-4488 Expression Induces NFκB Translocation in Venous Endothelial Cells Under Arterial Flow.

Authors:  Shao-Yu Fang; Chia-Wei Huang; Tzu-Chieh Huang; Anjali Yadav; Jeng-Jiann Chiu; Chia-Ching Wu
Journal:  Cardiovasc Drugs Ther       Date:  2021-02       Impact factor: 3.727

Review 8.  miRNAs in endothelial cell signaling: the endomiRNAs.

Authors:  Massimo M Santoro; S Nicoli
Journal:  Exp Cell Res       Date:  2012-12-19       Impact factor: 3.905

Review 9.  Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction.

Authors:  Suzanne M Eken; Hong Jin; Ekaterina Chernogubova; Lars Maegdefessel
Journal:  J Diabetes Res       Date:  2013-11-27       Impact factor: 4.011

10.  Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells.

Authors:  Nathalie R Reinhard; Suzanne F van Helden; Eloise C Anthony; Taofei Yin; Yi I Wu; Joachim Goedhart; Theodorus W J Gadella; Peter L Hordijk
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.